SBRA NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Sabra Healthcare REIT Inc · Real Estate · Reit - Healthcare Facilities

Open interactive chart View report data Download investor PDF
Latest close 22.36 USD
11.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 14.0% above the Trend Line and sits at 96.9% of its 52-week range. The latest completed week returned 11.2%, after a 14.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 48/100 conviction, while the latest news-sentiment score is 59/100. Near-term considerations: price is close to its 52-week high; earnings are due in 4d.

Setup score 72 out of 100
Latest Close 22.36 USD 24 Jul 2026
1W Return 11.2% latest completed week
4W Return 14.4% short-term follow-through
12W Return 11.4% quarterly tape
Trend Breadth 90.4% 47 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 11.2% Latest completed week; four-week move 14.4%. Indicator stack 60/59 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 59.40% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 48/100 conviction; expected move 5.8%. News sentiment 59/100 50 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 14.0% above the Trend Line and sits at 96.9% of its 52-week range. The latest completed week returned 11.2%, after a 14.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6512-week average 0.79

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.65Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 14.4% over four weeks, 11.4% over 12 weeks, and 30.5% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W11.2%
4W14.4%
12W11.4%
26W22.3%
52W30.5%
Active trend streak3 weeks
Active weeks in one year47
Trend breadth90.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.02Latest activity-pressure read.
Pressure change103.1%Four-week change in activity pressure.
Leadership8.34Latest relative-leadership reading.
RS change195.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength39/100Blend of value, momentum, and quality. Underlying universe rank 62; rank 1 is best.
Value14/100Relative valuation strength. Underlying universe rank 87; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum73/100Medium-term price momentum. Underlying universe rank 28; rank 1 is best.
Growth33/100Revenue and earnings growth. Underlying universe rank 68; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
36.1x
Price divided by trailing earnings.
Price / sales
6.9x
Market value relative to trailing revenue.
EV / EBITDA
17.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
63.5%
Gross profit retained from each unit of revenue.
Operating margin
33.2%
Operating profit retained from revenue.
Free-cash-flow margin
45.1%
Free cash flow generated from revenue.
Return on invested capital
5.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
12.9%
Latest one-year revenue growth.
EPS growth
11.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
8.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
5.4%
Cash dividends relative to market value.
Buyback yield
-4.0%
Net share repurchases relative to market value.
Shareholder yield
1.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
5.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

SBRA shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.03, expected move of 5.8%, and Sharemaestro trend signal active.

Conviction48/100
Expected move5.8%
Put/call volume0.03
Pressure100
Speculation7
Volatility48
Trend agreement0
Open options detail
Insider activity16 / 4

16 acquisitions and 4 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment59/100

Weighted news tone is neutral across 50 relevant articles.

25 positive · 25 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move5.8%Nearest-chain priced movement where available.
52-week drawdown-0.8%Distance below the 52-week high.
13-week volatility4.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+11.2%Week of 24 Jul.
Worst week-7.2%Week of 5 Jun.
Latest week+11.2%Week of 24 Jul.

Shape of recent returns

Strong gains3
Modest gains14
Flat weeks0
Modest losses6
Sharp losses3
Recent vol4.7%13-week weekly-return volatility.
Base vol3.2%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew2.6% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape69/100

Trend, activity pressure, participation, and risk combine to a 69/100 tape read.

 Indicator analysis41/100

Latest 12-week confirmation: trend 8/12, activity pressure 5/12, relative leadership 1/12.

Activity pressure 0.65; 3 reversal markers Next-Week ExpectancyPositive 59.40%

Next-week expectancy is positive with a 59.40% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors49/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 81; Small Cap Core rank 86 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options46/100

SBRA shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.03, expected move of 5.8%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 5.8% Sentiment59/100

Weighted news tone is neutral across 50 relevant articles.

Healthcare of Ontario Pension Plan Trust Fund Has $11.29 Million Holdings in Sabra Healthcare REIT, Inc. $SBRA Insiders16 / 4

16 acquisitions and 4 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202622.36 USD11.2%19.62 USD15.65 USD0.028.3420.9MOn
17 Jul 202620.11 USD2.5%19.49 USD15.57 USD-0.33-3.9715.2MOn
10 Jul 202619.62 USD-2.7%19.42 USD15.51 USD-0.53-10.2912.6MOn
3 Jul 202620.16 USD3.2%19.39 USD15.45 USD-0.64-6.4212.2MOff
26 Jun 202619.54 USD7.8%19.34 USD15.38 USD-0.80-8.7124.6MOff
19 Jun 202618.12 USD-3.3%19.32 USD15.32 USD-0.92-19.3416.0MOff
12 Jun 202618.73 USD1.5%19.32 USD15.26 USD-0.62-14.8515.8MOff
5 Jun 202618.46 USD-7.2%19.29 USD15.20 USD-0.28-14.4919.2MOn
29 May 202619.89 USD-4.0%19.28 USD15.15 USD0.07-12.339.8MOn
22 May 202620.72 USD0.2%19.18 USD15.08 USD0.42-6.3110.5MOn
15 May 202620.67 USD1.1%19.07 USD15.00 USD0.36-5.618.1MOn
8 May 202620.45 USD1.9%18.96 USD14.92 USD0.38-7.0810.6MOn
1 May 202620.07 USD1.3%18.84 USD14.85 USD0.34-4.1616.9MOn
24 Apr 202619.80 USD-2.9%18.75 USD14.78 USD0.18-4.1710.6MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.